Allen Bond

Premature Ejaculation Treatment Industry 2016 Industry Analysis, Top Players, Revenue and Market Share Report

Press Release   •   Jan 25, 2018 14:43 IST

Study on Premature Ejaculation Treatment Market by Infinium Global research is comprehensive presentation of qualitative and quantitative research to identify key trends, growth prospects, drivers, restraints and opportunities in the Global market. The report also deep dives into the sub-segments of Premature Ejaculation Treatment Market by type (oral therapies; nonselective serotonin reuptake inhibito, selective serotonin reuptake inhibitor; topical therapies) through main geographies in the Global Market such as North America, Europe, Asia-Pacific and RoW. Browse through over 100 tables and figures to get complete view of the global and regional markets of Premature Ejaculation Treatment over the period of 2016 to 2022.

The global market for premature ejaculation treatment was valued at around USD 1.2 billion in 2015 and is expected to reach USD 2.6 billion by 2022, growing at a CAGR of around 11.6% during the forecast period of 2016 to 2022. Premature ejaculation is uncontrolled ejaculation either before or shortly after sexual penetration. It happens with minimal sexual stimulation and before the person wishes. It may result in unsatisfactory sex for both partners. This can increase the anxiety that may add to the problem. It is one of the most common forms of male sexual dysfunction. It has probably affected every man at some point in his life.

Erectile Ddysfunction (ED) and Premature Eejaculation (PE) are the two most prevalent male sexual dysfunctions. The Global Study of Sexual Attitudes and Behaviors and other sources suggests a global prevalence of PE of approximately 20-30% across all age groups. Chances of sexual dysfunction increases with age, physical inactivity, smoking, diabetes, stress and prostate concerns.

Get a Sample Report @

Worldwide approximately 100 million men are estimated to suffer from male sexual dysfunction. Rise in base of population with sexual disorders, changing lifestyle habits such as smoking, and drinking alcohol and increasing stress levels in the men due to the work life are some of the driving factors of this market. In addition, large number of drugs under pipeline for FDA approval and introduction of novel techniques are further expected to boost the market growth in the coming years.

Companies profiled:

  • Janssen Pharmaceutica N. V. (a pharmaceutical company of Johnson and Johnson)
  • Plethora Solutions Holdings PLC
  • Akorn Pharmaceuticals
  • Absorption Pharmaceuticals
  • Allergan
  • Innovus Pharmaceuticals
  • GlaxoSmithKline
  • Pfizer

Make an Enquiry @

Key topics covered:

1. Scope of the report

2 Executive summary
3 Qualitative analysis

4 Global premature ejaculation market, by type, 2016 - 2022

5 Global premature ejaculation market, by geography, 2016 - 2022

6 Company profiles

Click to View Complete Report @